Encompass Health CAO sells 5,211 shares at $120.93

Rhea-AI Filing Summary

Encompass Health Corp (EHC) reported that Chief Accounting Officer Andrew L. Price sold Encompass Health Common Stock in a non-derivative transaction. On 2026-08-31, he sold 5,211 shares at $120.93 per share in an open market or private transaction. Following this sale, he directly holds 69,483 shares of Encompass Health Common Stock. The filing does not indicate that the transaction was made under a Rule 10b5-1 trading plan.

Insider Trade Summary

Net Seller: 5,211 shares

Net Sell 1 txn

Insider Price Andrew L

Role Chief Accounting Officer

Sold 5,211 shs ($630K)

Type	Security	Shares	Price	Value
Sale	Encompass Health Common Stock	5,211	$120.93	$630K

Holdings After Transaction: Encompass Health Common Stock — 69,483 shares (Direct)

Key Figures

Shares sold: 5,211 shares Sale price per share: $120.93 per share Shares held after transaction: 69,483 shares +1 more

4 metrics

Shares sold 5,211 shares Non-derivative sale of Encompass Health Common Stock on 2026-08-31

Sale price per share $120.93 per share Price for the 5,211 shares sold on 2026-08-31

Shares held after transaction 69,483 shares Direct ownership of Encompass Health Common Stock following the sale

Number of sale transactions 1 transaction Single reported non-derivative sale by Andrew L. Price

Key Terms

non-derivative, Rule 10b5-1, open market or private transaction, Chief Accounting Officer

4 terms

non-derivative financial

"the transaction is classified as a non-derivative transaction"

Rule 10b5-1 regulatory

"aff_10b5_one indicates the Rule 10b5-1 checkbox status"

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

open market or private transaction financial

"transaction_code_description: Sale in open market or private transaction"

Chief Accounting Officer other

"Andrew L. Price is listed with the title Chief Accounting Officer"

A chief accounting officer is a senior executive responsible for overseeing a company's financial records and ensuring all accounting practices are accurate and compliant with regulations. They play a key role in preparing financial reports that help investors understand the company's financial health, much like a trusted navigator guiding a ship through complex waters. Their work ensures transparency and trust in the company's financial information.

FAQ

What insider transaction did Encompass Health Corp (EHC) disclose for Andrew L. Price?

Encompass Health Corp disclosed that Chief Accounting Officer Andrew L. Price sold 5,211 shares of Encompass Health Common Stock on 2026-08-31 in a non-derivative sale transaction.

At what price did Andrew L. Price sell Encompass Health (EHC) shares?

Andrew L. Price sold Encompass Health Common Stock at $120.93 per share on 2026-08-31 in a sale classified as an open market or private transaction.

How many Encompass Health (EHC) shares does Andrew L. Price hold after this sale?

After the reported sale, Andrew L. Price directly holds 69,483 shares of Encompass Health Common Stock.

Was the Encompass Health (EHC) insider sale made under a Rule 10b5-1 plan?

The filing indicates the Rule 10b5-1 checkbox as false, so the reported sale by Andrew L. Price was not affirmed as being made pursuant to a Rule 10b5-1 trading plan.

What role does Andrew L. Price hold at Encompass Health Corp (EHC)?

Andrew L. Price is identified as the Chief Accounting Officer of Encompass Health Corp in the insider ownership report.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/01/2026 - 12:22 PM Accepted by SEC EDGAR 09/01/2026 - 12:21 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Price Andrew L

(Last) (First) (Middle)

9001 LIBERTY PARKWAY

(Street)

BIRMINGHAM ALABAMA 35242

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Encompass Health Corp [ EHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Accounting Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/31/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Encompass Health Common Stock	08/31/2026		S		5,211	D	$120.93	69,483	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ Patrick Darby, attorney-in-fact for Mr. Price	09/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)